60 Degrees Pharmaceuticals (SXTPW) Cost of Revenue (2022 - 2025)
Historic Cost of Revenue for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $537690.0.
- 60 Degrees Pharmaceuticals' Cost of Revenue rose 38142.58% to $537690.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $779090.0, marking a year-over-year increase of 8866.68%. This contributed to the annual value of $384765.0 for FY2024, which is 1892.0% down from last year.
- As of Q3 2025, 60 Degrees Pharmaceuticals' Cost of Revenue stood at $537690.0, which was up 38142.58% from $50051.0 recorded in Q2 2025.
- Over the past 5 years, 60 Degrees Pharmaceuticals' Cost of Revenue peaked at $537690.0 during Q3 2025, and registered a low of $50051.0 during Q2 2025.
- For the 4-year period, 60 Degrees Pharmaceuticals' Cost of Revenue averaged around $133040.3, with its median value being $90922.5 (2022).
- Per our database at Business Quant, 60 Degrees Pharmaceuticals' Cost of Revenue tumbled by 5131.78% in 2024 and then soared by 38142.58% in 2025.
- Over the past 4 years, 60 Degrees Pharmaceuticals' Cost of Revenue (Quarter) stood at $162835.0 in 2022, then decreased by 10.18% to $146257.0 in 2023, then fell by 19.27% to $118077.0 in 2024, then surged by 355.37% to $537690.0 in 2025.
- Its last three reported values are $537690.0 in Q3 2025, $50051.0 for Q2 2025, and $73272.0 during Q1 2025.